Clarivate Analytics Plc (CLVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 295,200 | 370,700 | 356,800 | 587,600 | 272,408 |
| Receivables | 798,300 | 908,300 | 872,100 | 906,400 | 737,733 |
| Other current assets | 151,100 | 183,200 | 166,300 | 143,200 | 137,423 |
| TOTAL | $1,244,600 | $1,462,200 | $1,395,200 | $1,637,200 | $1,147,564 |
| Non-Current Assets | |||||
| PPE Net | 53,500 | 51,600 | 54,500 | 83,800 | 36,267 |
| Intangibles | 10,007,800 | 11,030,300 | 12,314,200 | 18,297,300 | 13,413,314 |
| Other Non-Current Assets | 184,300 | 162,700 | 181,000 | 164,700 | 193,549 |
| TOTAL | $10,245,600 | $11,244,600 | $12,549,700 | $18,545,800 | $13,643,130 |
| Total Assets | $11,490,200 | $12,706,800 | $13,944,900 | $20,183,000 | $14,790,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 30,600 | 28,600 |
| Accounts payable and accrued liabilities | 124,500 | 144,100 | 101,400 | 129,200 | 82,038 |
| Accrued Expenses | 429,300 | 441,700 | 485,200 | 679,600 | 569,682 |
| Other current liabilities | N/A | 6,700 | N/A | N/A | N/A |
| TOTAL | $1,433,500 | $1,600,000 | $1,559,800 | $1,902,000 | $1,423,093 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,518,700 | 4,721,100 | 5,005,000 | 5,456,300 | 3,457,900 |
| Deferred Revenues | 859,100 | 983,100 | 947,500 | 1,030,400 | 707,318 |
| Other Non-Current Liabilities | 109,100 | 105,100 | 213,000 | 464,500 | 466,520 |
| TOTAL | $4,917,700 | $5,114,500 | $5,572,600 | $6,355,100 | $4,332,815 |
| Total Liabilities | $6,351,200 | $6,714,500 | $7,132,400 | $8,257,100 | $5,755,908 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 691,638 | 666,286 | 674,428 | 683,151 | 607,980 |
| Common Shares | 12,978,800 | 11,740,500 | 11,744,700 | 11,827,900 | 9,989,284 |
| Retained earnings | -7,313,500 | -6,645,500 | -5,658,900 | -1,604,400 | -1,250,838 |
| Other shareholders' equity | -526,300 | -495,300 | -665,900 | 326,800 | 492,344 |
| TOTAL | $5,139,000 | $5,992,300 | $6,812,500 | $11,925,900 | $9,034,790 |
| Total Liabilities And Equity | $11,490,200 | $12,706,800 | $13,944,900 | $20,183,000 | $14,790,698 |